@inbook{422b9b5c9b2b4f11bf6e3a8d920cb165,
title = "A primer for cancer research programs on defining and evaluating the catchment area and evaluating minority clinical trials recruitment",
abstract = "National Cancer Institute (NCI) designated cancer centers are charged with reducing disparities, improving cancer-related health outcomes, and increasing clinical trial participation for the catchment area population. Succeeding in this endeavor requires a clear definition of each cancer center's geographic catchment area as well as the demographic characteristics of the populations residing in the catchment area. For this reason, the definition of the catchment area is now a required element of NCI grant applications. This primer provides detailed information related to the definition of cancer centers' catchment areas and provides a case example from the University of Texas MD Anderson Cancer Center to highlight best practice strategies for compiling and interpreting cancer health statistics for the catchment area.",
keywords = "Catchment area, Clinical trials, Demographics, Equity",
author = "Nguyen, {Lynne H.} and Cook, {Elise D.}",
note = "Funding Information: This work was supported in part by funding from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment, through the Center for Community-Engaged Translational Research. Many thanks to Michael J. Fisch, MD, MPH (Medical Director, Medical Oncology Programs and Genetics, AIM Specialty Health, Chicago, Illinois) for invaluable editorial assistance. We are also grateful to Electra D. Paskett, PhD (Professor of Cancer Research, Ohio State University Comprehensive Cancer Center, Columbus, Ohio) and Marian L. Neuhouser PhD, RD (Full Member and Program Head, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington) for their helpful comments on an earlier version of this manuscript. Funding Information: This work was supported in part by funding from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment, through the Center for Community-Engaged Translational Research. Many thanks to Michael J. Fisch, MD, MPH (Medical Director, Medical Oncology Programs and Genetics, AIM Specialty Health, Chicago, Illinois) for invaluable editorial assistance. We are also grateful to Electra D. Paskett, PhD (Professor of Cancer Research, Ohio State University Comprehensive Cancer Center, Columbus, Ohio) and Marian L. Neuhouser PhD, RD (Full Member and Program Head, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington) for their helpful comments on an earlier version of this manuscript. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",
year = "2020",
doi = "10.1016/bs.acr.2020.02.001",
language = "English (US)",
isbn = "9780128201763",
series = "Advances in Cancer Research",
publisher = "Academic Press Inc.",
pages = "219--226",
editor = "Ford, {Marvella E.} and Esnaola, {Nestor F.} and Salley, {Judith D.}",
booktitle = "Advances in Cancer Research",
}